|1.||Ratner, Buddy D: 2 articles (06/2007 - 01/2002)|
|2.||Castner, David G: 2 articles (06/2007 - 01/2002)|
|3.||Horbett, Thomas A: 2 articles (06/2007 - 01/2002)|
|4.||Cao, Lan: 1 article (06/2007)|
|5.||Lee, Chi-Ying: 1 article (06/2007)|
|6.||Sukavaneshvar, Sivaprasad: 1 article (06/2007)|
|7.||Chang, Mark: 1 article (06/2007)|
|8.||Wagner, Matthew S: 1 article (01/2002)|
|9.||Shen, Mingchao: 1 article (01/2002)|
|10.||Martinson, Laura: 1 article (01/2002)|
|1.||Foreign Bodies (Foreign Body)
01/01/2001 - "RF-GDPD tetraglyme coating provides a promising approach to make non-fouling biomaterials that can inhibit non-specific material-host interactions and reduce the foreign body response."
01/01/2002 - "Loosely bound proteins such as fibrinogen on polymerized tetraglyme may contribute to the adhesion of PMNs and macrophages and ultimately to fibrous encapsulation (the foreign body response) around the implants."
06/15/2007 - "Plasma-deposited tetraglyme surfaces greatly reduce total blood protein adsorption, contact activation, platelet adhesion, platelet procoagulant activity, and in vitro thrombus deposition."
06/15/2007 - "In the in vitro disturbed blood flow model, tetraglyme plasma coated catheters had 50% less thrombus than did the uncoated catheters. "
06/15/2007 - "The ability of tetraethylene glycol dimethyl ether (tetraglyme) plasma deposited coatings exhibiting ultralow fibrinogen adsorption to reduce blood activation was studied with six in vitro methods, namely fibrinogen and von Willebrand's factor adsorption, total protein adsorption, clotting time in recalcified plasma, platelet adhesion and procoagulant activity, and whole blood thrombosis in a disturbed flow catheter model. "
|1.||Fibrinogen (Factor I)
|3.||Proteins (Proteins, Gene)
|4.||Biocompatible Materials (Biomaterials)